USE OF A PK ACTIVATOR IN THE TREATMENT OF SICKLE CELL DISEASE
AR135547A1Pending Publication Date: 2026-09-30AGIOS PHARMACEUTICALS INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- ARP20250100771
- Authority / Receiving Office
- AR · AR
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-08-19
- Filing Date
- 2025-03-25
- Publication Date
- 2026-09-30
Need to check novelty before this filing date? Find Prior Art
No text content released.
Claims
This description provides methods for treating sickle cell disease comprising orally administering Compound 1 or a pharmaceutically acceptable salt of Compound 1, or a solvate of Compound 1, or a solvate of a pharmaceutically acceptable salt of Compound 1, or a pharmaceutical composition comprising Compound 1, or a pharmaceutically acceptable salt of Compound 1, or a solvate of Compound 1, or a solvate of a pharmaceutically acceptable salt of Compound 1, at specified doses.